PATENT CLAIM ANALYSIS

Application Number: 15747220
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "210200"]

Abstract:
The present invention relates to amide derivatives having dual pharmacological activity towards both the sigma (σ) receptor, and the μ-opioid receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.

Claim (Index 34):
The compound according to  claim 33 , wherein R 5  and R 5\u2032  are both hydrogen.

Metadata:
- Claim Count in Document: 74.0
- Percentile: 86.0
- Lexical Diversity: 1.35
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15746877', '15531810', '15571352', '16090403', '15315486']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8501346847793909
- 35 USC 102 Novelty (BERT): 0.5660418481100147
- Combined Prediction Score: 0.8217254011124533
- Mean Citation Score: 484.095566
- Max Citation Score: 527.3969
- Similarity Product: 327.5396562337636

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test